Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.
about
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer.Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck Cancer.
P2860
Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tenfibgen-DMAT Nanocapsule Del ...... ibition of Cell Proliferation.
@ast
Tenfibgen-DMAT Nanocapsule Del ...... ibition of Cell Proliferation.
@en
type
label
Tenfibgen-DMAT Nanocapsule Del ...... ibition of Cell Proliferation.
@ast
Tenfibgen-DMAT Nanocapsule Del ...... ibition of Cell Proliferation.
@en
prefLabel
Tenfibgen-DMAT Nanocapsule Del ...... ibition of Cell Proliferation.
@ast
Tenfibgen-DMAT Nanocapsule Del ...... ibition of Cell Proliferation.
@en
P2093
P2860
P1476
Tenfibgen-DMAT Nanocapsule Del ...... ibition of Cell Proliferation.
@en
P2093
Betsy T Kren
Gloria Niehans
Gretchen M Unger
Janeen H Trembley
Khalil Ahmed
Omar Cespedes Gomez
Rachel I Vogel
Vicci L Korman
P2860
P577
2014-01-01T00:00:00Z